You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Point of care blood coagulopathy diagnostics

    SBC: Coalesenz Inc.            Topic: DHA19A001

    We have developed a novel low-cost, multi-functional blood coagulation sensor that can measure a patient’s coagulation status within less than 10 minutes using a 25mL drop of blood. This device addresses the critical unmet need to identify and manage patients with an elevated risk of life-threatening bleeding or thrombosis, the major causes of in-hospital preventable death. In addition, our inno ...

    STTR Phase II 2020 Department of DefenseDefense Health Agency
  2. Battlefield Deployable Lab-on-a-chip for Rapid MDR Bacteria Detection and Quantification in Infected Wounds

    SBC: OPTOWARES INC            Topic: DHA201001

    US military service members experiencing combated-related wounds have high chances of developing infection by multidrug resistant (MDR) bacteria. MDR infection results in higher amputation rate, subsequent operations and extended recovery time. Currently there’s no FDA-cleared, deployable, rapid MDR bacteria testing assay. Optowares proposes to develop a portable, inexpensive lab-on-a-chip syste ...

    SBIR Phase I 2020 Department of DefenseDefense Health Agency
  3. Rapid Portable ID and AST Diagnostic for Infected Wound Infections

    SBC: GENECAPTURE, INC.            Topic: DHA201001

    GeneCapture is proposing to use its rapid CAPTURE assay (Confirm Active Pathogens Through Unamplified RNA Expression) to identify the pathogen(s) in wound infections. The pathogen Infection Diagnostic (ID)test takes place in a disposable cartridge that integrates and automates the sample prep steps and determines the genetic signature of the pathogens present. The assay is based on immobilized ste ...

    SBIR Phase I 2020 Department of DefenseDefense Health Agency
  4. First-in-class TREM-1 Radioprotector to Prevent the Effects of Acute Radiation Syndrome

    SBC: SIGNABLOK, INC.            Topic: DHA201002

    Problem. No FDA-approved prophylactic Medical Counter Measures (MCMs) are currently available for Ionizing Radiation (IR) exposures that result in Acute Radiation Syndrome (ARS), suggesting an unmet need for such agents. Objective. This is a proposal to develop a safe, well-tolerable and effective agent designed to prevent acute or late radiation effects and prolong survival. The main objective of ...

    SBIR Phase I 2020 Department of DefenseDefense Health Agency
  5. Automated Functional Nano-Material Discovery Platform for Developing Sensors

    SBC: TRITON SYSTEMS, INC.            Topic: DHA201003

    Triton Systems will design, build, and test a novel nanoparticle synthesis platform for use in application-specific soft sensors. This work will enable a disruptive advancement in development of self-directed machine learning (ML) algorithms for new materials discovery and sensor design. The development of this material and device will yield a rich data set of interrelated structure-function-manuf ...

    SBIR Phase I 2020 Department of DefenseDefense Health Agency
  6. Human Cell-Based Biosensor (HCB)

    SBC: SPZ TECHNOLOGIE LLC            Topic: DHA191006

    To address the US Army need in novel toxicity sensing methods using a platform compatible with the Environmental Sentinel Biomonitor (ESB) for testing Army field water with the goal of increasing toxicant sensitivity and reducing consumable size and cost, SPZ Technologies, LLC (SPZT) proposes to continue the development a Human Cell-Based Biosensor (HCB). The HCB is based on novel human cells lyop ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  7. Development of the MagAid for Simplified Pain Management During Prolonged Field Care Using Pulsed Magnetic Fields

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: DHA191011

    Over 50,000 American warfighters had been wounded in action in Operations Iraqi and Enduring Freedom with over 1,500 requiring major limb amputations. Warfighters and first responders must have proper tools for pain management during prolonged field care, allowing rapid stabilization and extraction while mitigating chronic pain effects. Recent studies indicate that magnetic fields can produce temp ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  8. Advanced Female Trauma Training System

    SBC: VCOM3D INC            Topic: DHP16002

    For this PhaseII SBIR, Vcom3D,with its subcontractors, the University of Washington and IVIR, Inc.,will develop an Advanced Female Trauma Training System (AFTTS) with realisticfemale anatomy, physiology, and behaviors. The AFTTS include both a Female Trauma Manikin and a tablet-based Virtual Instructor/Patient System (VIPS) thatcommunicates wirelessly with themanikin. The AFTTSwill includesensors ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  9. Real-Time Small-Volume Blood Sampling and Analysis for Coagulopathy of Trauma Analytes

    SBC: APTITUDE MEDICAL SYSTEMS INC            Topic: DHP15012

    Traumatic hemorrhage is the primary mechanism of death in potentially survivable combat injuries, and is the leading cause of death for civilians under the age of 44. A major underlying cause of this high mortality is Acute Traumatic Coagulopathy, a deadl

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  10. BurRapid Intracranial Access Platform with QuickICP and QuickVentric Attachments

    SBC: CRITICAL INNOVATIONS LLC            Topic: DHA17010

    Defense Health Agency (DHA) seeks to develop a new and innovative point of injury device to manage patients with moderate-to-severe traumatic brain injury (TBI). Critical Innovations, NeoMatRx, and KARA & Associates; OHSU School of Medicine Division of Tr

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government